Marks Group Wealth Management, Inc Astrazeneca PLC Transaction History
Marks Group Wealth Management, Inc
- $1.02 Billion
- Q2 2025
A detailed history of Marks Group Wealth Management, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 28,554 shares of AZN stock, worth $2.1 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
28,554
Previous 41,227
30.74%
Holding current value
$2.1 Million
Previous $3.03 Million
34.16%
% of portfolio
0.19%
Previous 0.3%
Shares
8 transactions
Others Institutions Holding AZN
# of Institutions
1,433Shares Held
507MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.21 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.63 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.35 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.31 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $228B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...